Allergan Inc was scheduled to begin clinical trials of bimatoprost solution last month, testing new formulations as a potential hair loss treatment. Bimatoprost, is the growth-stimulating ingredient in the popular eyelash medication Latisse.
According to the website clinicaltrials.gov, the trial will evaluate “the safety, tolerability and pharmacokinetics of a new formulation of bimatoprost following topical application in patients with alopecia.” Two different formulations will actually be tested.
Men and women age 18 to 64 with moderate male/female-pattern baldness are eligible for inclusion in the study. The clinical trial was scheduled to begin in October and be completed in February 2011.
What is Latisse?
Latisse is 0.03% bimatoprost solution, a medication that can help patients grow more prominent eyelashes. After several weeks of applying Latisse to the base of the upper eyelids, a person can grow lashes that are longer, thicker and darker. According to the Orange County Register, some physicians have offered the drug off-label for baldness treatment and seen “modest” results.
To learn more about purchasing Latisse in Wilmington, contact Azalea Coast Plastic Surgery.
